# To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions

> **NCT00913952** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 18 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fasting Conditions
- **DRUG:** Geneva 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions
- **DRUG:** Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed Conditions

## Key facts

- **NCT ID:** NCT00913952
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-04
- **Primary completion:** 1994-06
- **Final completion:** 1994-06
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00913952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00913952, "To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fed and Fasted Conditions". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00913952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*